Fechner J, Goy J, Artigou J Y, Bedu O, Loeper J, Emerit J, Grosgogeat Y
Presse Med. 1986 Jun 7;15(23):1077-80.
Malondialdehyde (MDA) as lipid peroxidation marker was studied in 27 patients with acute coronary insufficiency. Significantly elevated plasma levels as compared with controls were found in patients with myocardial necrosis and with preinfarction syndrome. No correlation was found between MDA and creatine phosphokinase, and a significant MDA decrease was observed at day 12: plasma MDA reached normal levels in the myocardial necrosis group. The MDA decrease was also significant in the preinfarction group, but the MDA level remained high in 4 patients with unstable angina. MDA is not a prognostic index. No correlation was found between MDA and plasma lipid levels or patients' ages. These data confirm that myocardial ischemia is associated with abnormal production of oxygen-derived free radicals which react with the membrane unsaturated fatty acids, resulting in toxic endoperoxides. This is thought to be one of the physio-pathological pathways which aggravate ischemic myocardial tissue damage.
对27例急性冠状动脉供血不足患者进行了丙二醛(MDA)作为脂质过氧化标志物的研究。在心肌坏死和梗死前综合征患者中发现,与对照组相比,其血浆水平显著升高。未发现MDA与肌酸磷酸激酶之间存在相关性,且在第12天观察到MDA显著下降:心肌坏死组血浆MDA达到正常水平。梗死前组的MDA下降也很显著,但4例不稳定型心绞痛患者的MDA水平仍较高。MDA不是一个预后指标。未发现MDA与血浆脂质水平或患者年龄之间存在相关性。这些数据证实,心肌缺血与氧衍生自由基的异常产生有关,这些自由基与膜不饱和脂肪酸发生反应,产生有毒的内过氧化物。这被认为是加重缺血性心肌组织损伤的生理病理途径之一。